Длинные некодирующие РНК: какие перспективы? programs associated with their suppressive and
oncogenic functions. Therefore, they can be excellent
Begliarzade, Sema,
Sufianov, Albert,
Ilyasova, Tatiana,
Shumadalova, Alina,
Sufianov, Rinat,
Beylerli, Ozal,
Yan, Zhongrui (2024) or inhibiting
oncogenic processes, depending on the specific cellular context. Recent studies have identified
Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) while also having the potential to act as
oncogenes. MiRNAs wield control over numerous processes within
or activation, influencing the expression of
oncogenes and tumor suppressor genes. Such alterations have
KHALIULLIN, F.A.,
KLEN, E.E.,
PAVLOV, V.N.,
SAMORODOV, A.V.,
SHEPILOVA, S.O.,
MAKAROVA, N.N.,
NURLANOVA, S.N.,
ABZALILOV, T.N. (2022) of in silico calculations predicted the absence of toxic risks (mutagenicity,
oncogenicity, reproductive
Begliarzade, Sema,
Beilerli, Aferin,
Sufianov, Albert,
Tamrazov, Rasim,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Liang, Yanchao,
Beylerli, Ozal (2023) tests such as
testing for
oncogenic types of human papillomavirus (HPV), cytology, colposcopy
LIU, W.,
ZHUANG, R.,
BAI, X.,
JIA, Z.,
KAPORA, E.,
TAN, W.,
FENG, S. (2020) blot assays showed that ASB16-AS1 functioned as an
oncogene by Wnt/β-catenin pathway. Conclusions
Пути развития иммунотерапии колоректального рака, while others exhibit
oncogenic activity. These miRNAs can be used as guides for epigenetic effects
-activated kinase (MEK), which suppress the increased activity of Ras
oncogenes. A promising issue is the study